Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Discover which Aristocrats ETF delivers the best value by fee and why cost matters for long-term returns. Learn quick tips to compare expense ratios and pick the right fund.
25,968 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Broadcom faced a sharp earnings-driven selloff, tumbling about 14% in a single day. This article spotlights an under-...
Savers with a traditional 401(K) around $1.4 million can trim future tax bite by executing a Roth-conversion plan in ...
Air-taxi stocks climb on a broad risk-on rally, with EHANG up about 18%, ARCHER up roughly 10%, and JOBY gaining abou...
Brinker International is moving from a multi-year tech upgrade to an AI-focused growth plan across Chili’s and Maggia...
When a Opendoor director sells a sizable stake, investors wonder if it hints at trouble or simply liquidity needs. Th...
Roughly 1 in 10 Medicare Advantage enrollees will lose their current plan for 2026 as insurers retreat from markets. ...
Micron Technology shares tumbled about 13% ahead of its fiscal Q3 print, but one analyst argues the slide is a sentim...
Sezzle's CEO argues BNPL market gains are siphoning wallet share from traditional lenders as the fintech reports stro...
Google’s looming compute constraint and a $462 billion backlog set the stage for a broader AI access debate. Investor...
A three-year high in core inflation is stirring worry for seniors who rely on Social Security. Frozen tax thresholds ...
Three leading egg producers settle with federal and state regulators over alleged price‑fixing, donating 53 million e...